Systematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...

The medical imaging industry is a somewhat consolidated oligopoly, with the top three players GEHC, Siemens Healthineers, and Philips controlling about 70% of the market. They largely compete by ...

Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

The global Humanized Mouse and Rat Model Market, valued at US$255.8 million in 2024, is forecasted to grow at a robust CAGR ...

Meet the world's youngest billionaire in the world, who inherited a centuries-old family business and now holds a net worth ...

Vishal Manchanda, Pharma Analyst at Systematix Group, advised avoiding companies with high dependence on the US market—such ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

The IFC, known as the world’s largest development institution focused on private sector growth in emerging markets, has ...

Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five ...

With President Trump's on-off tariffs causing huge uncertainty in recent weeks, some value stocks have been getting even ...

Drugmaker Mayne Pharma, which is the subject of a $672m foreign takeover bid, has painted a rosy earnings outlook for 2025, ...